Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.
Mevorach D, Reiner I, Grau A, Ilan U, Berkun Y, Ta-Shma A, Elpeleg O, Shorer Z, Edvardson S, Tabib A.
Mevorach D, et al.
Ann Neurol. 2016 Nov;80(5):708-717. doi: 10.1002/ana.24770. Epub 2016 Sep 19.
Ann Neurol. 2016.
PMID: 27568864
Clinical Trial.